Reduces spots and brightens the complexion

• Lily plant cells and Retinol-like active ingredient
• Ultra-concentrated formula
• Mature skin
• Vegan formula

Pigment spots are the result of an overproduction and irregular distribution of melanin, the skin's pigment. To counteract and limit this effect, we have developed a highly concentrated serum with a light, non-sticky texture. Indeed, the Lys Active® Concentrated Anti-Spot Serum provides a visible reduction in the intensity of spots for a more even and radiant complexion. Skin is smoothed and the complexion's radiance is revived.

The Lys Active® range puts the intelligence of nature at the service of the skin to help it age better. These treatments act on all visible signs of aging: dehydration, loss of firmness, lack of radiance, fine lines and wrinkles, spots…. Discover the effectiveness of our complete routine thanks to the unique synergy of two active ingredients:

• The active plant cells of White Lily(1,2,3,4) of French origin are obtained through an innovative and environmentally friendly extraction process that maximizes their wonderful properties. This active ingredient intensifies cell renewal and limits melanin transport, giving it regenerating and brightening power, reviving the complexion's radiance.
• The plant-based Retinol-like active ingredient(5,6,7,8) is extracted from Rambutan (Hairy Litchi) leaves. This active ingredient improves skin elasticity and firmness by stimulating collagen and elastin production while being better tolerated than the classic Retinol molecule. It also reduces wrinkles by significantly increasing collagen fiber density.
• Specific anti-spot active ingredient(9,10): Red Algae extract of French origin is a depigmenting active ingredient known to combat skin aging. It reduces spots, improves skin uniformity, and revives the complexion's radiance.

30% recycled glass bottle, guaranteed phthalate and Bisphenol A free.

Designed and manufactured in France.

(1) Clinical study (in-vivo) of the brightening effect on the facial skin of 30 women aged 35 to 65, over 56 days. 0.1% emulsion. Mexametric measurements.
(2) In-vitro study of PAR-2 concentration after 24h of treatment. Significant results from 0.5%
(3) In-vitro study of epidermal KI67 cell proliferation marking. Significant results from 0.5%
(4) Supplier document
(5) In-vitro genomic study by PCR at 0.03% on 88 genes.
(6) In-vitro proteomic study by Western blot at different percentages between 0.01% and 0.06% on 5 proteins of interest.
(7) Corilagin molecule titrated at 0.7-1.3% in the extract.
(8) In-vivo study at 0.1%: improvement in elasticity and wrinkles. Over 28 days with 28 women (55-65 years old). Measurements taken at D0 and D28. Comparison to placebo and vaseline.
(9) In-vivo test on 25 Caucasian female volunteers aged 60 (+/-6) for hands and 27 volunteers aged 33 (+/-8) for face. Objectified at 0.62% vs placebo. 56 days.
(10) In-vivo test on 34 Caucasian women aged 48 (+/- 7) by visual evaluation by experts + self-assessment questionnaires. Objectified at 0.46% vs placebo. 56 days.